1 / 1
|
DeCS
|
|
|
Descriptor English:
|
|
Clinical Trials, Phase II as Topic
|
Descriptor Spanish:
|
|
Ensayos Clínicos Fase II como Asunto
|
Descriptor Portuguese:
|
|
Ensaios Clínicos Fase II como Assunto
|
Synonyms English:
|
|
Drug Evaluation, FDA Phase 2 as Topic
Drug Evaluation, FDA Phase II as Topic
Evaluation Studies, FDA Phase 2 as Topic
Evaluation Studies, FDA Phase II as Topic
|
Tree Number:
|
|
E05.318.760.250.500.210
N05.715.360.775.088.500.210
N06.850.520.450.250.250.210
VS2.002.003.001.003.002
|
Definition English:
|
|
Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries. |
Indexing Annotation English:
|
|
for general design, methodology, economics, etc. of phase II clinical trials; a different heading CLINICAL TRIAL, PHASE II is used for reports of a specific phase II clinical trial
|
History Note English:
|
|
2008(1993)
|
Allowable Qualifiers English:
|
|
|
Record Number:
|
|
30783
|
Unique Identifier:
|
|
D017322
|
Occurrence in VHL:
|
|
|
Similar:
|
|
DeCS CID-10 LILACS
|